Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Androgen associated hepatocellular carcinoma with an aggressive course.

Literature DB >> 1655591

Androgen associated hepatocellular carcinoma with an aggressive course.

D Gleeson¹, M J Newbould, P Taylor, R F McMahon, B C Leahy, T W Warnes.

Abstract

The hepatocellular carcinomas that develop in patients treated with androgens have previously been associated with a benign clinical outcome. We describe a man who developed a hepatocellular carcinoma after 24 years of androgen treatment, whose tumour initially showed partial regression after withdrawal of androgens but subsequently pursued an aggressive and fatal course.

Entities: Disease Species

Mesh：

Substances：
Methyltestosterone

Year: 1991 PMID： 1655591 PMCID： PMC1379057 DOI： 10.1136/gut.32.9.1084

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

18 in total

Review 1. Hepatoma associated with androgen therapy for aplastic anemia.

Authors: A T Meadows; J L Naiman; M Valdes-Dapena
Journal: J Pediatr Date: 1974-01 Impact factor: 4.406

2. Long-term survival with tumor regression in androgen-induced liver tumors.

Authors: G W McCaughan; M J Bilous; N D Gallagher
Journal: Cancer Date: 1985-12-01 Impact factor: 6.860

3. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.

Authors: J Bruix; J M Barrera; X Calvet; G Ercilla; J Costa; J M Sanchez-Tapias; M Ventura; M Vall; M Bruguera; C Bru
Journal: Lancet Date: 1989-10-28 Impact factor: 79.321

2. Measurement of androgen receptor expression in adult liver, fetal liver, and Hep-G2 cells by the polymerase chain reaction.

Authors: A P Stubbs; J L Engelman; J I Walker; P Faik; G M Murphy; M L Wilkinson
Journal: Gut Date: 1994-05 Impact factor: 23.059

2 in total

Androgen associated hepatocellular carcinoma with an aggressive course.

Review 1. Hepatoma associated with androgen therapy for aplastic anemia.

2. Long-term survival with tumor regression in androgen-induced liver tumors.

3. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.

4. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.

5. Hepatoma and peliosis hepatis developing in a patient with Fanconi's anemia.

6. Androgenic-anabolic steroid therapy and hepatocellular carcinoma.

7. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.

8. Intracerebral haemorrhage. Accuracy of computerised transverse axial scanning in predicting the underlying aetiology.

9. Androgen-induced hepatoma.

10. Hepatic tumours induced by anabolic steroids in an athlete.

1. Cellular distribution of androgen receptors in the liver.

2. Measurement of androgen receptor expression in adult liver, fetal liver, and Hep-G2 cells by the polymerase chain reaction.